tofacitinib
CHEBI:CHEBI_71200
Definition
A pyrrolopyrimidine that is pyrrolo[2,3-d]pyrimidine substituted at position 4 by an N-methyl,N-(1-cyanoacetyl-4-methylpiperidin-3-yl)amino moiety. Used as its citrate salt to treat moderately to severely active rheumatoid arthritis.
Chemical Information
- Molecular Formula
- C16H20N6O
- Molecular Mass
- 312.36960
- Charge
- 0
- SMILES
- C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N
- InChI
- InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1
- InChIKey
- UJLAWZDWDVHWOW-YPMHNXCESA-N
Alternative Names
- 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
- CP 690550
- CP-690550
- Tasocitinib
- tofacitinib
- tofacitinibum
Drug Classification
-
pyrrolopyrimidineView Class →
CHEBI:38670
-
nitrileView Class →
CHEBI:18379
-
tertiary amino compoundView Class →
CHEBI:50996
-
N-acylpiperidineView Class →
CHEBI:48591
-
t279414
-
t279768
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:71200
- DRON_00010000
- 1357536
- oboInOwl#hasDbXref
- Wikipedia:Tofacitinib
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:71200
- rxcui
- 2478437
- active_ingredient_strength
- 22 mg/1
- manufacturer_name
- U.S. Pharmaceuticals
- active_ingredient_name
- TOFACITINIB CITRATE
- unii
- O1FF4DIV0D
- spl_set_id
- 68e3d6b2-7838-4d2d-a417-09d919b43e13
- upc
- 0300691001011
- pharm_class
- Janus Kinase Inhibitors [MoA]
- brand_name_suffix
- XR
- package_marketing_start_date
- 06-NOV-12
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- package_description
- 1 BAG in 1 DRUM (17337-0085-1) / 1 BAG in 1 BAG / 1 kg in 1 BAG
- package_ndc
- 42571-289-38
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- listing_expiration_date
- 20241231
- route
- ORAL
- marketing_start_date
- 20160307
- labeler_name
- Aurore Pharmaceuticals Private Limited
- application_number
- NDA208246
- spl_id
- 66feb773-64a1-bc65-e053-2991aa0a7b32
- product_type
- HUMAN PRESCRIPTION DRUG
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1357536
- oboInOwl#hasDbXref
- Wikipedia:Tofacitinib
- oboInOwl#id
- CHEBI:71200
- generic_name
- Tofacitinib Citrate Micronized
- dosage_form
- SOLUTION
- brand_name
- XELJANZ XR
- brand_name_base
- XELJANZ
- product_ndc
- 17337-0085
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_76617
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- has_treatment
- http://purl.obolibrary.org/obo/DOID_3118
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect33269
- owl#annotatedSource
- t280280
- owl#someValuesFrom
- t3745288